PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 7/25

Market Analysis and Trades for 7/25

PharmD_KS's avatar
PharmD_KS
Jul 24, 2025
∙ Paid
9

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 7/25
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here: Market Analysis for the Week of 7/20

Today was rather straightforward on ES. The primary order of business was whether or not bulls sustained above yesterday’s spike (base and high). The range was incredibly small, not quite making it to 6420, so there was very little room for execution much higher than the spike.

We can see that all of the action except for a single wick took place above yesterday’s spike base and most of the action was above yesterday’s high. We got a good low and firm rejection of prices below the spike base just before open.

NQ was definitely a better trading vehicle today so if ranges remain tight on ES I’ll continue to cover both but probably personally trade NQ. We did see the continued presence of a seller in the 23420s on NQ. That ranged has been tagged something like 9 times on 30-minute candles. I’ll discuss my thoughts on it in tonight’s plan/

Paid Content Below or in the Discord

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Keep reading with a 7-day free trial

Subscribe to PharmD Capital Trading with PharmD_KS to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share